PPT Research, Inc. v. Solvay USA, Inc.

CourtDistrict Court, E.D. Pennsylvania
DecidedJuly 17, 2024
Docket5:20-cv-02645
StatusUnknown

This text of PPT Research, Inc. v. Solvay USA, Inc. (PPT Research, Inc. v. Solvay USA, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
PPT Research, Inc. v. Solvay USA, Inc., (E.D. Pa. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA PPT RESEARCH, INC.,

Plaintiff, v. CIVIL ACTION NO. 20-2645 SOLVAY USA INC., et al.,

Defendants.

MEMORANDUM OPINION

Schmehl, J. /s/ JLS July 17, 2024 Before the Court is the Motion to Vacate the Final Arbitration Award filed by Plaintiff, PPT Research, Inc. (“Plaintiff” or “PPT”). Defendants, Solvay USA Inc. (“Solvay”) and Rhodia Operations S.A.S., (“Rhodia”) have also filed a Motion to Confirm the Arbitration Award. Having reviewed the parties’ briefing, I will deny PPT’s motion to vacate the award and grant Solvay and Rhodia’s motion to confirm the award. I. BACKGROUND PPT filed this proceeding pursuant to the Federal Arbitration Act , 9 U.S.C. § 1 et. seq. (“FAA”) to vacate an arbitration award made in a proceeding held by the International Court of Arbitration of the International Chamber of Commerce (“ICC Court”). The award in question addresses a contractual dispute between Solvay and Rhodia (collectively, “Defendants”), companies involved in the development, production, and sale of chemicals and polymers, and PPT, a company that developed technology involving an LVS micro-gel particle slurry suspension system (“LVS technology”). The action arises from two agreements between the parties: a reciprocal confidentiality agreement and a technology license agreement. Rhodia entered into a Reciprocal Confidentiality Agreement (“RCA”) on June 9, 2014, which provided for a temporary “Secrecy Period” from the time of the agreement to June 8, 2020. The RCA was amended on August 12, 2014, to add Solvay as a party. Under the amended RCA, any tests on the operational performance of the LVS technology by Rhodia were to

remain “Confidential Information” between the parties and the “sole property” of Rhodia. (ECF No. 30-2 ¶ 3; RCA, Section 2.6.) On February 20, 2015, Solvay and PPT entered into a Technology License Agreement (“TLA”), which granted Solvay an “exclusive license” to commercialize PPT products in China and Korea. (ECF No. 30-2 ¶ 5; TLA, Section 2(a).) Both agreements contained a dispute resolution clause providing for arbitration under the Rules of Arbitration of the International Chamber of Commerce. Defendants contend that Solvay entered into the TLA in reliance on PPT’s representations of favorable test site results of its LVS technology, because Solvay’s own ability to directly analyze the LVS technology was limited by PPT. (ECF No. 30-2 ¶ 55- 57; Claimants’ Statement of Claim (“SOC”), pages 4-6.) Under the TLA, Solvay was

allowed to “manufacture, have manufactured, use, sell or distribute the products” within China and Korea after receiving a technology package and training by PPT that would enable Solvay to commercialize the LVS technology. (ECF No. 30-2 ¶ 58; SOC at 6.) Solvay also agreed, in expectation of future product sales, to pay a one-time royalty fee advance of $100,000 and a licensing and technology transfer fee of $216,000 in monthly installments. (ECF No. 30-2 ¶ 60.) Over the course of two years, Solvay tried to solve technical problems with the LVS technology in multiple customer trials to no avail. (Id. at ¶ 62; SOC at 7; Braem Witness Statement (“CWS-1”), ¶ 37.) According to Mr. Mattias Braem of Solvay, the failure of the project was ultimately due to the intractable problem of caking that was the focus of the last trials, to which Solvay implemented almost all of PPT’s suggestions with no success. (ECF No. 30-2 ¶ 62; SOC at 7; CWS-1 at ¶¶ 51, 66.) At that time, even PPT agreed that there was nothing more for Solvay to do to commercialize the LVS

technology. (ECF No. 30-2 ¶ 62; SOC at 7; CWS-1 at ¶ 68.) However, by then, Solvay had expended more than $600,000 on the project but was “unable to make a single dollar in sale” and therefore no royalties ever came due. (ECF No. 30-2 ¶ 63; SOC at 7; CWS-1 at ¶¶ 37, 74.) After a telephone conference in which the parties agreed “to terminate the TLA,” (ECF No. 30-2 ¶ 64; CWS-1 at ¶ 77), Solvay sent PPT a letter on June 8, 2018, invoking the termination provisions of the TLA, stating that PPT was in material breach of the contract for failing to provide the technical information or training necessary to commercialize the LVS technology. (See ECF No. 30-2 ¶ 64; SOC at 8-9; CWS-1 ¶ 79.) On June 5, 2020, PPT filed a lawsuit against Defendants (claimants in that action) in the Eastern District of Pennsylvania (“EDPA Action”) for (a) alleged misappropriation

of PPT trade secrets; (b) alleged breach of the RCA and TLA; and (c) injunctive relief. PPT Research, Inc., v. Solvay USA Inc., et al., Case No. 20-2645 (E.D. Pa, June 5, 2020). Defendants, in response, filed a Request for Arbitration with the ICC Court and a motion in the EDPA Action to compel arbitration of any claims arising under the RCA and/or TLA, citing Section 6.2 of the RCA and Section 11(b) of the TLA. (ECF No. 30-2 ¶ 67, 70, 72.) On July 7, 2021, this Court granted Defendants’ motions to compel arbitration and filed an order stating in part that “[t]he parties shall proceed to ICC arbitration in this matter on all claims.” PPT Research, Case No. 20-2645. As set out in the RCA, the arbitration tribunal applied Delaware law as the applicable substantive law to claims and defenses relating to the RCA and Pennsylvania law and federal law as the applicable substantive law to claims and defenses relating to the TLA. Over the course of arbitration, two claims became uncontested. First, the Parties

agreed that the RCA is no longer in effect and the Parties have no continuing obligations arising out of the RCA. Second, the Parties agreed that Solvay effectively terminated the TLA in its letter dated June 8, 2017. As for the contested claims, the Tribunal concluded that (1) PPT materially breached the TLA by failing to provide a technology package and training of the LVS technology that would enable its commercialization as required under Section 5(b), and (2) Defendants’ claims are not time-barred based on the plain reading of Section 14(d) of the TLA, and PPT is thus not relieved of its liability for damages for its material breach. In sum, under the TLA, Solvay incurred losses and damages in the amounts of $35,312.23 in payments to PPT, $216,000 for the license and technology transfer, and $100,000 as a royalty fee advance. Defendants were also entitled to

arbitration costs in the amount of $46,500.00. Added together, the Tribunal found that PPT is liable to Defendants for $351,312.23 in damages for its material breach of the TLA and $46,500.00 in arbitration costs. After the entry of the final award as to damages, PPT petitioned this Court to vacate the arbitrator’s award. Defendants oppose PPT’s petition and seek confirmation of the award. For the reasons that follow, I will deny PPT’s petition to vacate the award. Instead, I will grant Defendants’ petition to confirm the entire award, as I find that the arbitrator met all standards required for confirmation of an arbitration award. II. STANDARD OF REVIEW An “extremely deferential standard of judicial review [is] set forth in the Federal Arbitration Act (“FAA”), 9 U.S.C.A. § 10(a)(1)-10(a)(4),” and a “district court may vacate [an award] only under exceedingly narrow circumstances.” Dluhos v.

Strasberg, 321 F.3d 365, 366 (3d Cir.2003), (citing 9 U.S.C. § 10); Amalgamated Meat Cutters & Butcher Workmen of N. Am., Local 195 v. Cross Brothers Meat Packers, Inc., 518 F.2d 1113, 1121 (3d Cir.1975). Pursuant to 9 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Dunkley v. Mellon Investor Services
378 F. App'x 169 (Third Circuit, 2010)
Teamsters Local 312 v. Matlack, Inc.
118 F.3d 985 (Third Circuit, 1997)
Oxford Health Plans LLC v. Sutter
133 S. Ct. 2064 (Supreme Court, 2013)
Western Filter Corp. v. Argan, Inc.
540 F.3d 947 (Ninth Circuit, 2008)
Stolt-Nielsen SA v. AnimalFeeds International Corp.
548 F.3d 85 (Second Circuit, 2008)
Krizovensky v. Krizovensky
624 A.2d 638 (Superior Court of Pennsylvania, 1993)
Steuart v. McChesney
444 A.2d 659 (Supreme Court of Pennsylvania, 1982)
Dluhos v. Strasberg
321 F.3d 365 (Third Circuit, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
PPT Research, Inc. v. Solvay USA, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/ppt-research-inc-v-solvay-usa-inc-paed-2024.